10X Genomics (TXG) PT Raised to $13 at UBS
Tweet
Share
E-mailGet Alerts TXG Hot Sheet
Price: $62.45 +1.48%
Rating Summary:
7 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 36
Rating Summary:
7 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 36
Join SI Premium – FREE
UBS analyst John Sourbeer raised the price target on 10X Genomics (NASDAQ: TXG) to $13.00 (from $12.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Jury finds Parse Biosciences willfully infringed 10x Genomics patents
- Affirm Holdings (AFRM) PT Raised to $110 at Bernstein SocGen Group
- BRC Inc. (BRCC) PT Raised to $25 at DA Davidson to Adjust for Reverse Split
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
